---
schema_version: "secwatch.filing_event.v1"
accession: "0000105770-24-000075"
form_type: "8-K"
ticker: "WST"
cik: "0000105770"
company_name: "WEST PHARMACEUTICAL SERVICES INC"
filed_at: "2024-10-24T23:59:59+00:00"
generated_at: "2026-05-30T10:19:19.726386+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# West Pharma Q3 EPS $1.85 (down from $2.14); raises FY2024 guidance, boosts dividend 5%

## Summary
- Q3 net sales $746.9M flat YoY; reported EPS $1.85 vs $2.14; adjusted EPS $1.85 vs $2.16.
- FY2024 guidance raised: net sales $2.875B-$2.905B, adjusted EPS $6.55-$6.75 (prior $6.35-$6.65).
- Dividend increased 5% to $0.21/share, payable Nov 20, 2024, record Nov 13, 2024.
- Proprietary Products net sales $601.4M (-0.2%); Contract-Manufactured $145.5M (+0.4%).
- Nine-month free cash flow $191.2M (-32.7%); share repurchases $506.5M in 9M 2024.

## SEC filing metadata
- accession: 0000105770-24-000075
- form_type: 8-K
- ticker: WST
- cik: 0000105770
- company_name: WEST PHARMACEUTICAL SERVICES INC
- filed_at: 2024-10-24T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/105770/000010577024000075/0000105770-24-000075-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/105770/000010577024000075/wst-20241024.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000105770-24-000075
- JSON: https://secwatch.observer/filing/0000105770-24-000075.json
- Plain text: https://secwatch.observer/filing/0000105770-24-000075.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.